TITLE:
Combination Pharmacotherapy for Smoking Cessation Among Methadone Patients

CONDITION:
Tobacco Use Disorder

INTERVENTION:
Combined intervention

SUMMARY:

      The purpose of this pilot study is to examine the effects of combined pharmacotherapy
      (Zyban/NRT)/behavioral treatment on smoking cessation among methadone maintenance therapy
      patients.
    

DETAILED DESCRIPTION:

      This is a one-arm, open label pilot study of MMT patients to determine whether bupropion,
      nicotine replacement therapy, and behavioral counseling is a feasible and potentially
      effective intervention for smoking cessation. The smoking behaviors of participants will be
      be followed for 6 months post quit-date to determine effect-size estimates for a future,
      large scale trial.
    

ELIGIBILITY:
Gender: All
Age: 18 Years to 70 Years
Criteria:

        Inclusion Criteria:

          -  Patients in long-term methadone maintenance treatment

          -  Patient smokes at least 10 cigarettes per day, are stable on their use of methadone
             (phase 2 or higher treatment), smoked for at least 1 year, be willing to participate
             for 6 months, and not have used bupropion or nicotine replacement therapy for 6
             months

        Exclusion Criteria:

          -  Patients who use prescription drug regimens that might affect methadone or bupropion
             metabolism

          -  Patients with cardiovascular disease, asthma, COPD

          -  Patients who are pregnant or breastfeeding

          -  Patients with regular use of alcohol, other illicit drugs, or other types of tobacco
             (chewing or pipe for example)
      
